RSNA 2022 – Accelerating digitally enabled care…

Dr. Randall Jones is one of the speakers this year. Come visit the GE Healthcare Booth #7324 on Nov. 30th at 1:35pm CT.

Dr. Randall Jones participates in GE’s Innovation Theater at RSNA Dec 2022

Dr. Randall Jones, CEO of BotImage and two other AI companies chosen to participate with GE HealthCare presenting during GE’s Innovation

New Studies Demonstrate that Bot Image’s Prostate Cancer AI Software Outperforms the Field

Bot Image, Inc., a Nebraska and Maine based Artificial Intelligence medical device company (, raised the performance bar with its

ProstatID kick-starts your Prostate MRI program

ProstatID, THE AI software FDA-cleared for not only detection and diagnosis of PCa, but also for screening using bpMRI.   Yes,

Prostate Cancer Treatment can be safely delayed and inexpensively and accurately monitored thanks to AI

Bot Image, Inc., a Nebraska and Maine based Artificial Intelligence medical device company, has received FDA-clearance on its ProstatIDTM AI

A Trailblazing Entrepreneur, Bringing Highly Accurate MRI Interpretation Software to Physicians

DR. RANDALL W. JONES FOUNDER & CEO OF BOT IMAGE, INC From joining the military at a young age to excelling at civilian jobs to…

Bot Image Makes the List: 10 Most Advanced Medical Imaging Solution Providers 2022

Bot Image Inc: Facilitating Early Detection through Disruptive Technology In undetermined and unsettled times, one must be open to…

Just released by Dr. Randall W Jones

Just released, The Healthcare Disruptor, by Dr. Randall W Jones. Dr. Jones writes about his journey from rural cowboy to medical device expert and CEO challenging the healthcare system with his inventions…

Omaha-Based MRI Medical Device Company, Bot Image, Receives FDA Clearance for AI

FOR IMMEDIATE RELEASE Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to…

ConcertAI’s TeraRecon and Bot Image, Inc. Partnership 

 TeraRecon, on March 18, 2023 CAMBRIDGE, Mass., Mar. 18,2023  /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, now